MarketCap
Castle Biosciences CSTL
€ 22.30
2.7%
Facebook
X
Telegram
Land |
 Vereinigte Staaten |
IPO-Jahr |
2019 |
Branche |
Diagnostik & Forschung |
Börse |
NASDAQ GLOBALSPB |
Anteile |
29 M |
Marktkapitalisierung |
$ 739 M |
EBITDA (LTM) |
$ -20.7 M |
P/E (LTM) |
-19.8 |
P/S (LTM) |
2.02 |
EPS (LTM) |
-1.25 |
Andere Aktien der Branche "Diagnostik & Forschung"
| Name | Preis | % 24h | Marktkapitalisierung | Börse | Land | |
|---|---|---|---|---|---|---|
 |
Enzo Biochem
ENZ
|
- | -8.98 % | $ 14.8 K | NYSE | USA |
 |
Heska Corporation
HSKA
|
- | - | $ 1.31 B | Nasdaq Capital Market,SPB | USA |
 |
DermTech
DMTK
|
- | -11.32 % | $ 2.94 M | Nasdaq Capital Market,SPB | USA |
 |
Centogene N.V.
CNTG
|
- | -6.23 % | $ 30.6 M | Nasdaq Global Market |  Germany |
|
Akumin
AKU
|
- | -17.87 % | $ 25.9 M | Nasdaq Capital Market |  Canada |
 |
Celcuity
CELC
|
$ 88.34 | -2.0 % | $ 4.13 B | Nasdaq Global Select Market | USA |
 |
Myriad Genetics
MYGN
|
$ 5.7 | 0.71 % | $ 528 M | Nasdaq Global Select Market,SPB | USA |
 |
NeoGenomics
NEO
|
$ 14.24 | 1.64 % | $ 1.82 B | Nasdaq Global Select Market,SPB | USA |
 |
Neogen Corporation
NEOG
|
$ 9.61 | -2.24 % | $ 2.08 B | Nasdaq Global Select Market,SPB | USA |
 |
Aspira Women's Health
AWH
|
- | -6.19 % | $ 10.5 M | Nasdaq Capital Market,SPB | USA |
 |
Accelerate Diagnostics
AXDX
|
- | -61.36 % | $ 2.46 M | Nasdaq Global Select Market | USA |
 |
Natera
NTRA
|
$ 264.69 | 0.18 % | $ 36.2 B | Nasdaq Global Select Market,SPB | USA |
 |
OPKO Health
OPK
|
$ 1.17 | -0.85 % | $ 812 M | Nasdaq Global Select Market | USA |
 |
Biocept
BIOC
|
- | -13.05 % | $ 7.29 M | Nasdaq Capital Market | USA |
 |
Pacific Biosciences of California
PACB
|
$ 1.4 | 1.45 % | $ 420 M | Nasdaq Global Select Market,SPB | USA |
 |
Oxford Immunotec Global PLC
OXFD
|
- | - | $ 562 M | Nasdaq Global Select Market |  Britain |
 |
Co-Diagnostics
CODX
|
$ 2.21 | -3.07 % | $ 2.94 M | Nasdaq Capital Market | USA |
 |
Chembio Diagnostics
CEMI
|
- | 0.22 % | $ 16.8 M | Nasdaq Capital Market | USA |
 |
Check-Cap Ltd.
CHEK
|
- | - | $ 9.42 M | Nasdaq Capital Market |  Israel |
 |
HTG Molecular Diagnostics
HTGM
|
- | -20.0 % | $ 1.06 M | Nasdaq Capital Market | USA |
 |
Global Cord Blood Corporation
CO
|
- | - | $ 399 M | NYSE |  China |
 |
Neuronetics
STIM
|
$ 1.88 | -2.59 % | $ 124 M | Nasdaq Global Select Market | USA |
 |
Fluidigm Corporation
FLDM
|
- | 1.08 % | $ 308 M | Nasdaq Global Select Market | USA |
 |
Genetic Technologies Limited
GENE
|
- | - | $ 7.1 B | Nasdaq Capital Market |  Australia |
 |
Genetron Holdings Limited
GTH
|
- | 0.12 % | $ 80.1 M | Nasdaq Global Market | China |
 |
PRA Health Sciences, Inc.
PRAH
|
- | - | $ 10.7 B | Nasdaq Global Select Market | USA |
 |
Twist Bioscience Corporation
TWST
|
$ 92.44 | -1.88 % | $ 5.53 B | Nasdaq Global Select Market,SPB | USA |
 |
Exact Sciences Corporation
EXAS
|
- | - | $ 19.8 B | Nasdaq Capital Market,SPB | USA |
 |
CareDx, Inc
CDNA
|
$ 37.61 | -0.45 % | $ 2 B | Nasdaq Global Market,SPB | USA |
 |
QIAGEN N.V.
QGEN
|
- | - | $ 10.6 B | NYSE |  Niderland |
 |
Soleno Therapeutics
SLNO
|
- | - | $ 2.69 B | Nasdaq Capital Market | USA |
 |
DarioHealth Corp.
DRIO
|
$ 7.47 | -5.44 % | $ 29.8 M | Nasdaq Capital Market | Israel |
 |
Quest Diagnostics Incorporated
DGX
|
$ 227.9 | 8.61 % | $ 25.3 B | NYSE,SPB | USA |
 |
Motus GI Holdings
MOTS
|
- | -34.28 % | $ 263 K | Nasdaq Global Select Market | Israel |
 |
Biomerica
BMRA
|
$ 1.6 | 0.34 % | $ 3.68 M | Nasdaq Capital Market | USA |
 |
Invitae Corporation
NVTA
|
- | - | $ 21.2 M | NYSE,SPB | USA |
 |
Organovo Holdings
ONVO
|
- | -2.3 % | $ 19.4 M | Nasdaq Capital Market | USA |
 |
OpGen
OPGN
|
- | -16.95 % | $ 1.54 M | Nasdaq Capital Market | USA |
 |
Anixa Biosciences
ANIX
|
$ 3.75 | 6.53 % | $ 122 K | Nasdaq Capital Market | USA |
 |
PerkinElmer
PKI
|
- | -0.91 % | $ 14.7 B | NYSE,SPB | USA |
 |
Mettler-Toledo International
MTD
|
$ 1 331.87 | 3.57 % | $ 27.5 B | NYSE,SPB |  Schweiz |
 |
DexCom
DXCM
|
$ 70.48 | -1.33 % | $ 27.5 B | Nasdaq Global Select Market,SPB | USA |
 |
Psychemedics Corporation
PMD
|
- | -1.84 % | $ 15.3 M | Nasdaq Global Select Market | USA |
 |
ICON Public Limited Company
ICLR
|
$ 170.32 | 1.82 % | $ 13.4 B | Nasdaq Global Select Market,SPB |  Irlanda |
 |
Quotient Limited
QTNT
|
- | -11.32 % | $ 1.1 M | Nasdaq Global Select Market | Schweiz |
 |
T2 Biosystems
TTOO
|
- | -39.35 % | $ 313 K | Nasdaq Global Select Market | USA |
 |
Renalytix AI plc
RNLX
|
- | 5.66 % | $ 22.7 M | Nasdaq Global Market | Britain |
 |
Syneos Health
SYNH
|
- | - | $ 4.46 B | Nasdaq Global Select Market,SPB | USA |
 |
Meridian Bioscience
VIVO
|
- | - | $ 1.49 B | Nasdaq Global Select Market | USA |
 |
Surmodics
SRDX
|
- | - | $ 608 M | Nasdaq Global Select Market,SPB | USA |